(Press-News.org) Children living with attention deficit hyperactivity disorder (ADHD) tend to feel that they benefit from medication to treat the condition and do not feel that the medication turns them into 'robots', according to a report published today. In fact, they report feeling that medication helps them to control their behaviour and make better decisions. The study, which gives a voice to the children themselves, provides valuable insights into their experiences and the stigma they face.
The ADHD VOICES – Voices on Identity, Childhood, Ethics and Stimulants – study has worked with 151 families in the UK and US to examine ethical and societal issues surrounding ADHD, and in particular the use of treatments such as methylphenidate (Ritalin). The project has been led by biomedical ethicist Dr Ilina Singh from King's College London and was funded by the Wellcome Trust.
Dr Singh and colleagues interviewed children and their families about ADHD, behaviour, medication and identity across four contexts – home, school, doctor's office and peer group. The findings of their study, which are announced today, are accompanied by a series of short films by award-winning animators The Brothers McLeod. The report is intended not only to highlight ethical and social issues surrounding ADHD, but also to help families, doctor, teachers and the children themselves to understand from a child's perspective what it is like to live with ADHD.
"ADHD is a very emotive subject which inspires passionate debate. Everyone seems to have an opinion about the condition, what causes it, how to deal with children with ADHD, but the voices of these children are rarely listened to," explains Dr Singh. "Who better to tell us what ADHD is like and how medication affects them than the children themselves?"
Dr Singh points to the controversies surrounding providing medication to children with ADHD, which some people argue turns the children into 'robots'. She believes that in many cases and with a correct diagnosis, treating with stimulants is appropriate and beneficial, particularly if complemented by other interventions. The evidence from the children that she interviewed suggests that they see medication as improving their ability to make their own moral choices.
Glenn, aged 10 from the US, says: "If you're like driving in a car, and like, there's two different ways, and you usually always go this way…and then one day you want to go the other way, but… the ADHD acts as like a blocker, so you can't… It [the medicine] opens the blocker so that you can go [the right] way. But you still have the choice of going the wrong way… It's harder [without medication], that's what's the truth. But it's not like [on medication] you're a robot..."
Dr Singh also found that children often did not understand their condition or why they were receiving medication. Many children in the study reported that they had little meaningful contact with their doctors. After the initial evaluation, clinic visits tended to focus on side-effect checks during which children were weighed and measured. Most children were not asked any questions during these visits.
Roger, age 13, from the UK, says: "I've only just started going to the ADHD clinic, but I haven't actually been to it properly, like, I've seen the doctor and he's talked about [ADHD] and I get weighed.. But ... they don't, they'll just say like, parts of what it is but then, like, they'll stop, so they will only say some of it and then, like change the subject."
Dr Singh argues that children need to be better informed and able to discuss their condition. "Given the ethical concerns that arise from ADHD diagnosis and stimulant drug treatment, it is imperative that children are able to openly discuss the value of diagnosis and different treatments with a trusted professional."
The report concludes with a series of recommendations for how parents, doctors and teachers can help children cope with and better understand their condition, and begin to tackle the stigma that currently exists around the condition.
Professor Peter Hill, a child and adolescent psychiatrist, says: "We hope that the VOICES Study and the ADHD and Me animations will inspire people to think differently about ADHD, drug treatments and children with behavioural difficulties. Behaving differently around these children is the main challenge. We hope that the strategies we have outlined will help improve the interactions with these children and help improve their lives."
Clare Matterson, Director of Medical Humanities and Engagement at the Wellcome Trust, comments: "It is refreshing to hear the voices of children included in the debate about ADHD. It is a very emotive subject and despite the fact that these children are at the centre of this debate, they are too often ignored. This report sends a clear message to doctors, teachers and parents about the importance of talking to children about their condition – and more importantly, listening to what they have to say."
INFORMATION:
Children with ADHD find medication frees them to choose between right and wrong, study suggests
2012-10-17
ELSE PRESS RELEASES FROM THIS DATE:
Where the deer and the antelope cross
2012-10-17
The locations of the structures completed this fall were informed by data collected by WCS, the Wyoming Cooperative Fish and Wildlife Research Unit, and the Wyoming Game and Fish Department, and identified the pronghorn's preferred migration routes and highway crossing points.
WCS has long studied an approximately 93-mile (150 km) migration of pronghorn between wintering grounds in the Upper Green River Basin and summering grounds in Grand Teton National Park (GTNP)—a migration corridor known as the "Path of the Pronghorn." WCS worked with many partners including ...
New insights into how genetic differences influence breast cancer risk from low-dose radiation
2012-10-17
Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have identified tissue mechanisms that may influence a woman's susceptibility or resistance to breast cancer after exposure to low-dose ionizing radiation, such as the levels used in full-body CT scans and radiotherapy.
The research could lead to new ways to identify women who have higher or lower risks of breast cancer from low-dose radiation. Such a predictive tool could help guide the treatment of cancer patients who may be better served by non-radiation therapies.
The ...
Overcoming memories that trigger cocaine relapse
2012-10-17
Researchers from the University of Wisconsin-Milwaukee (UWM) have identified mechanisms in the brain responsible for regulating cocaine-seeking behavior, providing an avenue for drug development that could greatly reduce the high relapse rate in cocaine addiction.
The research reveals that stimulation of certain brain receptors promotes inhibition of cocaine-associated memories, helping addicts to stop drug use. This inhibition is achieved through enhancing a process called "extinction learning," in which cocaine-associated memories are replaced with associations that ...
Shark social networking
2012-10-17
University of Delaware researchers are using an underwater robot to find and follow sand tiger sharks that they previously tagged with transmitters. The innovative project is part of a multi-year partnership with Delaware State University to better understand the behavior and migration patterns of the sharks in real time.
"In the past week our new, specially equipped glider OTIS – which stands for Oceanographic Telemetry Identification Sensor – detected multiple sand tiger sharks off the coast of Maryland that were tagged over the past several years," said Matthew Oliver, ...
Fresh out of high school, 2 Chicago students present research at AAPS Annual Meeting
2012-10-17
Arlington, Va. — Two Chicago high school students have developed a novel treatment method to reduce the negative effects of Fetal Alcohol Syndrome (FAS) and a new understanding of genetics behind the disease. This research is being presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in Chicago, Ill., Oct. 14 – 18. More than 8,000 attendees are expected at the largest conference dedicated to the pharmaceutical sciences.
Ayana Jamal and Ariella Hoffman-Peterson, 2012 graduates of Niles North High School in Skokie, ...
Prolonged formula feeding, delay in solid foods associated with increased risk for pediatric ALL
2012-10-17
This abstract will be presented at a press conference hosted by program chairperson Cory Abate-Shen, Ph.D., the Michael and Stella Chernow professor of urological oncology and associate director of the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, in the San Simeon AB Room on the fourth floor of the Hilton Anaheim at 7:30 a.m. PT on Wednesday, Oct. 17. Reporters who cannot attend in person can call in using the following information:
U.S./Canada (toll free): 1 (800) 446-2782
International (toll call): 1 (847) 413-3235
ANAHEIM, ...
Study finds vegetable-derived compound effective in treating triple-negative breast cancer
2012-10-17
Arlington, Va. — A new compound created from a rich source in vegetables including broccoli and brussel sprouts has been developed to combat triple-negative breast cancer (TNBC). This research is being presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Chicago, Ill., on Oct. 14 – 18, during Breast Cancer Awareness Month.
TNBC accounts for approximately 15-20 percent of all breast cancer cases in the U.S. It is one of the most aggressive forms of breast ...
Novel chewing gum formulation helps prevent motion sickness
2012-10-17
Arlington, Va. — A new prototype for medicated chewing gum has been developed for motion sickness that may offer many advantages over conventional oral solid dosage forms. About 33 percent of people are susceptible to motion sickness in mild circumstances and 66 percent are affected in more severe conditions. This research is being presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in Chicago, Ill., Oct. 14 – 18, an international event anticipating more than 8,000 attendees.
Lead researcher Mohsen Sadatrezaei of ...
Discovery of two opposite ways humans voluntarily forget unwanted memories
2012-10-17
If only there were a way to forget that humiliating faux pas at last night's dinner party. It turns out there's not one, but two opposite ways in which the brain allows us to voluntarily forget unwanted memories, according to a study published by Cell Press October 17 in the journal Neuron. The findings may explain how individuals can cope with undesirable experiences and could lead to the development of treatments to improve disorders of memory control.
"This study is the first demonstration of two distinct mechanisms that cause such forgetting: one by shutting down ...
Daily multivitamins reduce risk of cancer in men
2012-10-17
Boston, MA – A daily multivitamin can help a man reduce his risk of cancer, according to new research from Brigham and Women's Hospital (BWH). The first-of-its kind study will be presented October 17 at the 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research and published online the same day in the Journal of the American Medical Association.
"The Physicians' Health Study II is the first clinical trial to test the affects of multivitamins on a major disease such as cancer," said lead author J. Michael Gaziano, MD, chief of the Division ...